Related Experiment Video

Updated: Aug 21, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis

Piyali Dasgupta1, Jiazhi Sun, Sheng Wang

  • 1Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Dr., Tampa, FL 33612, USA.

Molecular and Cellular Biology
|October 16, 2004
PubMed

Insights

Growth factor stimulation inactivates the retinoblastoma tumor suppressor protein (Rb) via Raf-1 kinase, independent of other cell cycle regulators. Disrupting this interaction inhibits tumor growth and blood vessel formation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • The retinoblastoma tumor suppressor protein (Rb) is crucial for regulating cell cycle progression.
  • Rb inactivation, through phosphorylation, is essential for cells to enter the S phase of the cell cycle.
  • The precise mechanism by which growth factor signals interact with the cell cycle machinery to inactivate Rb remains unclear.

Purpose of the Study:

  • To elucidate the role of Raf-1 kinase in the mitogenic signaling pathway that leads to Rb inactivation.
  • To investigate the timing and independence of the Rb-Raf-1 interaction relative to other cell cycle regulators.
  • To assess the therapeutic potential of disrupting the Rb-Raf-1 interaction in controlling proliferative disorders.

Main Methods:

  • Investigated the direct binding of Raf-1 kinase to Rb following growth factor stimulation in quiescent cells.
  • Assessed the Rb-Raf-1 interaction's independence from mitogen-activated protein kinase cascades and cyclin-dependent kinases.
  • Utilized a nine-amino-acid peptide to disrupt the Rb-Raf-1 interaction and evaluated its effects on cell proliferation and angiogenesis.
  • Administered the peptide via a carrier molecule in a mouse model to assess in vivo efficacy.

Main Results:

  • The Rb-Raf-1 interaction occurs before cyclin and/or cyclin-dependent kinase activation, facilitating normal cell cycle progression.
  • Raf-1-mediated Rb inactivation is independent of the MAPK cascade and CDKs.
  • Raf-1 binding correlated with the dissociation of Brg1 from Rb.
  • Disruption of the Rb-Raf-1 interaction inhibited Rb phosphorylation, cell proliferation, and vascular endothelial growth factor-mediated capillary tubule formation.
  • In vivo, peptide delivery resulted in a significant reduction in tumor volume and microvessel formation.

Conclusions:

  • Raf-1 kinase acts as a critical link between mitogenic signaling and the retinoblastoma protein.
  • The Rb-Raf-1 interaction is a key event in initiating cell cycle progression.
  • Targeting the Rb-Raf-1 interaction holds promise for developing novel therapeutic strategies against proliferative disorders and cancer.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...